Literature DB >> 10712423

RANKing the importance of measles virus in Paget's disease.

F P Ross1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10712423      PMCID： PMC292462          DOI： 10.1172/JCI9557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  CD34 expression by stromal precursors in normal human adult bone marrow.

Authors:  P J Simmons; B Torok-Storb
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

Review 3.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

4.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.

Authors:  N Kurihara; S V Reddy; C Menaa; D Anderson; G D Roodman
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

6.  c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.

Authors:  A E Grigoriadis; Z Q Wang; M G Cecchini; W Hofstetter; R Felix; H A Fleisch; E F Wagner
Journal:  Science       Date:  1994-10-21       Impact factor: 47.728

7.  Canine distemper virus localised in bone cells of patients with Paget's disease.

Authors:  M T Gordon; D C Anderson; P T Sharpe
Journal:  Bone       Date:  1991       Impact factor: 4.398

8.  A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.

Authors:  M F Roussel; J R Downing; C W Rettenmier; C J Sherr
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307
View more
  12 in total

1.  Interactions between immune and bone cells: new insights with many remaining questions.

Authors:  J Lorenzo
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 3.  Role of RANKL and RANK in bone loss and arthritis.

Authors:  D Holstead Jones; Y-Y Kong; J M Penninger
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

4.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathway.

Authors:  M H A Malik; A Bayat; F Jury; W E R Ollier; P R Kay
Journal:  Int Orthop       Date:  2006-04-01       Impact factor: 3.075

6.  The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Authors:  Michael W-H Wang; Shi Wei; Roberta Faccio; Sunao Takeshita; Pablo Tebas; William G Powderly; Steven L Teitelbaum; F Patrick Ross
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation.

Authors:  Shu Yan; Lujie Miao; Yahua Lu; Liangzhi Wang
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

8.  Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts.

Authors:  Shankari N Somayaji; Samantha Ritchie; Mahnaz Sahraei; Ian Marriott; Michael C Hudson
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells.

Authors:  Ying Cao; Shu-Fang Jia; Geetika Chakravarty; Benoit de Crombrugghe; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2008-01       Impact factor: 5.852

10.  Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.

Authors:  Evan Romas; Natalie A Sims; Daphne K Hards; Mandy Lindsay; Julian W M Quinn; Peter F J Ryan; Colin R Dunstan; T John Martin; Matthew T Gillespie
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.